13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples